Oncology & Cancer

Study reveals a major mechanism driving kidney cancer progression

The shortage of oxygen, or hypoxia, created when rapidly multiplying kidney cancer cells outgrow their local blood supply can accelerate tumor growth by causing a nuclear protein called SPOP—which normally suppresses tumor ...

Oncology & Cancer

Kidney cancer progression linked to shifts in tumor metabolism

Investigators in The Cancer Genome Atlas (TCGA) Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer, clear ...

Oncology & Cancer

New drug may help immune system fight cancer

(HealthDay)—An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.

Oncology & Cancer

Experimental drug beneficial in NIH trial to treat a rare sarcoma

(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from this largest clinical ...

page 8 from 13